Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 57, Issue 2

Issues

A single-center performance evaluation of the fully automated iFlash anti-Müllerian hormone immunoassay

Jun Jing
  • Jinling Hospital, Nanjing University School of Medicine, Reproductive Medical Center, Nanjing, Jiangsu, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Fuzhen Xia
  • Jinling Hospital, Nanjing University School of Medicine, Reproductive Medical Center, Nanjing, Jiangsu, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Zheng Ding
  • Nanjing Jiangning Hospital, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Li Chen
  • Jinling Hospital, Nanjing University School of Medicine, Reproductive Medical Center, Nanjing, Jiangsu, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Yong Shao
  • Jinling Hospital, Nanjing University School of Medicine, Reproductive Medical Center, Nanjing, Jiangsu, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Yi-Feng Ge
  • Jinling Hospital, Nanjing University School of Medicine, Reproductive Medical Center, Nanjing, Jiangsu, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Peng Pan
  • Jinling Hospital, Nanjing University School of Medicine, Reproductive Medical Center, Nanjing, Jiangsu, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Tian Tian
  • Jinling Hospital, Nanjing University School of Medicine, Reproductive Medical Center, Nanjing, Jiangsu, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Xiao-Peng Lan
  • Fuzhou General Hospital of Nanjing Military Command Area, Department Laboratory, Fuzhou, Fujian, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Bing Yao
  • Corresponding author
  • Jinling Hospital, Nanjing University School of Medicine, Reproductive Medical Center, No. 305 Zhongshan East Road, Nanjing, 210002 Jiangsu, P.R. China
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2018-07-18 | DOI: https://doi.org/10.1515/cclm-2018-0371

References

  • 1.

    Jamil Z, Fatima SS, Ahmed K, Malik R. Anti-Mullerian hormone: above and beyond conventional ovarian reserve markers. Dis Markers 2016;2016:5246217.PubMedWeb of ScienceGoogle Scholar

  • 2.

    Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 2014;20:370–85.Web of SciencePubMedCrossrefGoogle Scholar

  • 3.

    Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update 2014;20:688–701.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 4.

    Kumar A, Kalra B, Patel A, McDavid L, Roudebush WE. Development of a second generation anti-Mullerian hormone (AMH) ELISA. J Immunol Methods 2010;362:51–9.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 5.

    Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update 2015;21:698–710.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 6.

    Fleming R, Fairbairn C, Gaudoin M. Objective multicentre performance of the automated assays for AMH and estimation of established critical concentrations. Hum Fertil (Camb) 2017;8:1–5.Google Scholar

  • 7.

    Li HW, Wong BP, Ip WK, Yeung WS, Ho PC, Ng EH. Comparative evaluation of three new commercial immunoassays for anti-Mullerian hormone measurement. Hum Reprod 2016;31:2796–802.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 8.

    Demirdjian G, Bord S, Lejeune C, Masica R, Riviere D, Nicouleau L, et al. Performance characteristics of the Access AMH assay for the quantitative determination of anti-Mullerian hormone (AMH) levels on the Access* family of automated immunoassay systems. Clin Biochem 2016;49:1267–73.Web of ScienceCrossrefPubMedGoogle Scholar

  • 9.

    Gassner D, Jung R. First fully automated immunoassay for anti-Mullerian hormone. Clin Chem Lab Med 2014;52:1143–52.PubMedWeb of ScienceGoogle Scholar

  • 10.

    Whiting G, Ferguson J, Fang M, Pepin D, Donahoe P, Matejtschuk P, et al. Quantification of Mullerian inhibiting substance/anti-Mullerian hormone polypeptide by isotope dilution mass spectrometry. Anal Biochem 2018;6. pii: S0003-2697(18)30222-7. DOI: 10.1016/j.ab.2018.05.006. [Epub ahead of print].Web of ScienceGoogle Scholar

About the article

aJun Jing and Fuzhen Xia contributed equally to this work.


Received: 2018-04-15

Accepted: 2018-06-20

Published Online: 2018-07-18

Published in Print: 2018-12-19


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: This work was supported by the Research Funds for Jiangsu Province Key Research and Development Plan (grant number BE2016750) and Jiangsu province key medical talents (grant number ZDRCA2016096) and the Research Funds for Military Family Planning (grant number 16JS012) to B. Yao. The Research Funds for Nanjing Jinling Hospital (grant number 2016041) to J. Jing.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 57, Issue 2, Pages e19–e22, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2018-0371.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Supplementary Article Materials

Comments (0)

Please log in or register to comment.
Log in